Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Methadone based ERAS

Phase 3Small molecule

SSenthil Sadhasivam

1

Indications

2

Total Trials

2

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Pediatric Cardiac SurgeryRecruiting

Pediatric Cardiac SurgeryPhase 3

Recruiting

Timeline

Expected Milestones

Q3 2029

Phase 3Recruiting

Idiopathic Scoliosis

NCT06626503

Phase 3Recruiting

Pediatric Cardiac Surgery

NCT06626035

Clinical

Trials by Indication[1]

Idiopathic Scoliosis1 trial

Prospective Randomized Evaluation of Analgesia for Spine Fusion Elective Surgery in Children (PRECISE Spine Trial)

Recruiting·SSenthil Sadhasivam·Phase 3·NCT06626503·500 enrolled

Pediatric Cardiac Surgery1 trial

Prospective Randomized Evaluation of Analgesia for Cardiac Elective Surgery in Children (PRECISE Cardiac Trial)

Recruiting·SSenthil Sadhasivam·Phase 3·NCT06626035·500 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Methadone based ERAS. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Methadone based ERAS compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Methadone based ERAS. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Senthil Sadhasivam company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: SSenthil Sadhasivam

Related News